Question

A 59-year-old with obesity, T2DM, and a recent HF hospitalization (LVEF 38%) is on ACE inhibitor and β‑blocker. Which addition provides mortality and HF hospitalization benefit?

Accepted Answer

SGLT2 inhibitor

Answer

Ivabradine

Answer

Vericiguat

Answer

Hydralazine-isosorbide dinitrate regardless of race

Answer

Amiodarone

Practice question

A 59-year-old with obesity, T2DM, and a recent HF hospitalization (LVEF 38%) is on ACE inhibitor and β‑blocker. Which addition provides mortality and HF hospitalization benefit?